Compare CLBK & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CLBK | QDEL |
|---|---|---|
| Founded | 1927 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Savings Institutions | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | CLBK | QDEL |
|---|---|---|
| Price | $17.17 | $28.57 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 1 | 6 |
| Target Price | $17.00 | ★ $39.33 |
| AVG Volume (30 Days) | 113.3K | ★ 1.1M |
| Earning Date | 01-27-2026 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.15 | N/A |
| Revenue | $202,015,000.00 | ★ $2,714,400,000.00 |
| Revenue This Year | $33.24 | N/A |
| Revenue Next Year | $12.96 | $2.42 |
| P/E Ratio | $117.45 | ★ N/A |
| Revenue Growth | ★ 0.49 | N/A |
| 52 Week Low | $12.64 | $19.50 |
| 52 Week High | $17.44 | $49.45 |
| Indicator | CLBK | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 72.46 | 58.72 |
| Support Level | $16.70 | $26.84 |
| Resistance Level | $17.40 | $30.40 |
| Average True Range (ATR) | 0.38 | 1.14 |
| MACD | 0.08 | 0.35 |
| Stochastic Oscillator | 89.50 | 54.76 |
Columbia Financial Inc is a federally chartered savings bank that serves the financial needs of depositors and the local community as a community-minded, customer service-focused institution. It offers traditional financial services to businesses and consumers. It attracts deposits from the general public and uses those funds to originate a variety of loans, including multifamily and commercial real estate loans, commercial business loans, one-to-four family real estate loans, construction loans, home equity loans and advances, and other consumer loans, and also offers a broad range of insurance products, investment solutions, and wealth management services.
QuidelOrtho Corp is engaged in the development, manufacturing and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if its revenue from North America.